AstraZeneca PLC vs Taiwan Semiconductor Manufacturing Company Limited
A head-to-head of AstraZeneca PLC (AZN) and Taiwan Semiconductor Manufacturing Company Limited (TSMWF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | AZN | TSMWF |
|---|---|---|
| Market Cap | $289.41B | $447.07B |
| P/E (TTM) | 14.26 | 8.52 |
| Forward P/E | 18.12 | 14.71 |
| P/S | 4.93 | 0.11 |
| P/B | 3.00 | 2.70 |
| EV/EBITDA | 16.16 | 9.34 |
| Dividend Yield | 3.41% | 3.23% |
| Profit Margin | 17.41% | 44.57% |
| Gross Margin | 81.90% | 59.89% |
| Operating Margin | 23.40% | 50.83% |
| Revenue Growth (YoY) | +4.11% | +20.45% |
| FCF Yield | 3.65% | 221.97% |
| Debt / Equity | 58.11 | 16.73 |
| Current Ratio | 0.94 | 2.51 |
Which is better: AstraZeneca PLC or Taiwan Semiconductor Manufacturing Company Limited?
- ✓Larger by market cap: Taiwan Semiconductor Manufacturing Company Limited
- ✓Cheaper valuation (lower P/E): Taiwan Semiconductor Manufacturing Company Limited
- ✓Higher dividend yield: AstraZeneca PLC
- ✓More profitable (net margin): Taiwan Semiconductor Manufacturing Company Limited
- ✓Faster revenue growth: Taiwan Semiconductor Manufacturing Company Limited
- ✓Higher free-cash-flow yield: Taiwan Semiconductor Manufacturing Company Limited
Across 13 available metrics, Taiwan Semiconductor Manufacturing Company Limited leads 11–2.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare AstraZeneca PLC with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.